Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biosimilar erythropoietin in anemia treatment (BEAT)-Efficacy and safety of a 1:1 dose conversion from EPREX® to EPIAO® in patients with end-stage renal disease on hemodialysis: A prospective, randomized, double blind, parallel group study.
Miao B, Isachkina AN, Shutov EV, Selyutin AA, Kvitkova LV, Shilo VY, Vetchinnikova ON, Alexandrov IV, Perlin DV, Zuev AV, Davydkin IL, Mironova TP, Solovyova OM, Tutin AP, Omelchenko AM, Vareesangthip K, Khadikova NG, Li M, Li X. Miao B, et al. Among authors: davydkin il. Medicine (Baltimore). 2022 Nov 25;101(47):e31426. doi: 10.1097/MD.0000000000031426. Medicine (Baltimore). 2022. PMID: 36451454 Free PMC article. Clinical Trial.
[The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial].
Kulagin AD, Bakirov BA, Davydkin IL, Elykomov IV, Konstantinova TS, Korobkin AV, Kosinova MV, Mazurov VI, Minaeva NV, Proidakov AV, Ptushkin VV, Shatokhin YV, Lin'kova YN, Zinkina-Orikhan AV, Morozova MA. Kulagin AD, et al. Among authors: davydkin il. Ter Arkh. 2021 Nov 15;93(11):1340-1348. doi: 10.26442/00403660.2021.11.201226. Ter Arkh. 2021. PMID: 36286657 Clinical Trial. Russian.
Postcovid-19 Asthenic Syndrome.
Zolotovskaia IA, Shatskaia PR, Davydkin IL, Shavlovskaya OA. Zolotovskaia IA, et al. Among authors: davydkin il. Neurosci Behav Physiol. 2022;52(2):191-195. doi: 10.1007/s11055-022-01222-6. Epub 2022 Mar 18. Neurosci Behav Physiol. 2022. PMID: 35317270 Free PMC article.
Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab.
Kulagin AD, Ptushkin VV, Lukina EA, Davydkin IL, Korobkin AV, Shamrai VS, Konstantinova TS, Kaporskaya TS, Mitina TA, Ksenzova TI, Zuev EV, Markova OA, Gapchenko EV, Kudlay DA. Kulagin AD, et al. Among authors: davydkin il. Ann Hematol. 2021 Nov;100(11):2689-2698. doi: 10.1007/s00277-021-04624-7. Epub 2021 Aug 16. Ann Hematol. 2021. PMID: 34398258 Free PMC article. Clinical Trial.
42 results